ATS 2023 Respiratory Innovation Summit

During the ATS 2023 Respiratory Innovation Summit, APIE Therapeutics presented a poster demonstrating preclinical efficacy of APT101 in a lung fibrosis model
Date/Time: May 20, 2023
Title: Apelin/APJ Agonists as a Novel Therapeutic Target for Lung Fibrosis Upstream and Downstream of Disease Pathophysiology
Authors: Willette RN1, Alegria E1, Runyon S2, Maitra R2
1) APIE-Therapeutics Inc. 2) Research Triangle Park